TP53 and sarcoma: Sequence analysis of 40 representative index tumors that could be examined for LOH of Tp53, revealed LOH in 55% of the tumors, which was strongly associated with sarcomas (bone and soft tissue) in contrast to non-sarcoma tumors (15/18 vs 7/24; p = 0.0015, Fisher’s exact test; Fig. 4b).